Chengdu Kanghong Pharmaceutical Group Co., Ltd

SZSE:002773 Stock Report

Market Cap: CN¥18.1b

Chengdu Kanghong Pharmaceutical Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Xiao Ke

Chief executive officer

CN¥2.0m

Total compensation

CEO salary percentagen/a
CEO tenure14.5yrs
CEO ownership8.7%
Management average tenureno data
Board average tenure6.6yrs

Recent management updates

Recent updates

With EPS Growth And More, Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Makes An Interesting Case

Dec 12
With EPS Growth And More, Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Makes An Interesting Case

Insufficient Growth At Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE:002773) Hampers Share Price

Sep 15
Insufficient Growth At Chengdu Kanghong Pharmaceutical Group Co., Ltd (SZSE:002773) Hampers Share Price

Here's Why We Think Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Is Well Worth Watching

Jun 21
Here's Why We Think Chengdu Kanghong Pharmaceutical Group (SZSE:002773) Is Well Worth Watching

Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Price Is Right But Growth Is Lacking After Shares Rocket 40%

May 12
Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Price Is Right But Growth Is Lacking After Shares Rocket 40%

Lacklustre Performance Is Driving Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Low P/E

Mar 27
Lacklustre Performance Is Driving Chengdu Kanghong Pharmaceutical Group Co., Ltd's (SZSE:002773) Low P/E

CEO

Xiao Ke (41 yo)

14.5yrs

Tenure

CN¥2,045,500

Compensation

Mr. Xiao Ke serves as a General Manager and President of Chengdu Kanghong Pharmaceuticals Group Co., Ltd., and Director since June 21, 2010 and served as Vice President.


Board Members

NamePositionTenureCompensationOwnership
Xiao Ke
GM, President & Director14.5yrsCN¥2.05m8.73%
CN¥ 1.6b
Jin Qun Yin
VP & Director8.3yrsCN¥5.85m0.038%
CN¥ 6.9m
Jian Rong Zhong
VP & Director16.5yrsCN¥1.43m1.15%
CN¥ 208.1m
Lin Wang
Non-Independent Director13.5yrsno datano data
Demin Zhou
Independent Director1.3yrsCN¥50.00kno data
Zhirong Zhang
Non-Independent Director1.3yrsno datano data
Jian Qun Yang
Employee Representative Supervisor5yrsno data0.0016%
CN¥ 294.9k
Zun Hong Ke
Chairman of the Board23.8yrsCN¥1.32m22.58%
CN¥ 4.1b
Wen Xian Gong
Chairman of the Supervisory Board13.5yrsno data3.55%
CN¥ 641.8m
Yin Ying Yang
Employee Supervisor5yrsno datano data
Hongguang Deng
Independent Director1.3yrsCN¥50.00kno data
Nan Xu
Independent Director1.3yrsCN¥50.00kno data

6.6yrs

Average Tenure

54yo

Average Age

Experienced Board: 002773's board of directors are considered experienced (6.6 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/24 17:39
End of Day Share Price 2024/12/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Chengdu Kanghong Pharmaceutical Group Co., Ltd is covered by 14 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Weiya ZhangBOCI Research Ltd.
Yue GaoChangjiang Securities Co. LTD.
Ziyu HeChina International Capital Corporation Limited